文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

中性粒细胞减少症与抗生素:何时用、用什么、怎么用及为什么用?

Neutropenia and antibiotics: when, what, how and why?

机构信息

Division of Infectious Diseases, Department of Medicine, City of Hope National Medical Center, Duarte.

Division of Infectious Diseases and Global Health, University of California, San Diego, La Jolla, CA, USA.

出版信息

Curr Opin Infect Dis. 2023 Aug 1;36(4):218-227. doi: 10.1097/QCO.0000000000000932. Epub 2023 Jun 12.


DOI:10.1097/QCO.0000000000000932
PMID:37431552
Abstract

PURPOSE OF REVIEW: Our aim is to review recent literature on antibiotic use in patients with neutropenia. RECENT FINDINGS: Prophylactic antibiotics are associated with risks and have limited mortality benefit. While early antibiotic use in febrile neutropenia (FN) is critical, early de-escalation or discontinuation may be safe in many patients. SUMMARY: With an increasing understanding of potential risks and benefits of use and improved risk assessment, paradigms of antibiotic use in neutropenic patients are changing.

摘要

目的综述:我们旨在综述中性粒细胞减少症患者抗生素使用的最新文献。

最近发现:预防性使用抗生素存在风险,且对死亡率的获益有限。虽然发热性中性粒细胞减少症(FN)患者早期使用抗生素至关重要,但许多患者早期降阶梯或停药可能是安全的。

总结:随着对抗生素使用潜在风险和获益的认识不断提高,以及风险评估的改善,中性粒细胞减少症患者抗生素使用的模式正在发生变化。

相似文献

[1]
Neutropenia and antibiotics: when, what, how and why?

Curr Opin Infect Dis. 2023-8-1

[2]
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.

Eur J Cancer. 2006-10

[3]
Pre-emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer.

Cochrane Database Syst Rev. 2022-11-28

[4]
Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.

Cochrane Database Syst Rev. 2012-10-17

[5]
The use of Open Dialogue in Trauma Informed Care services for mental health consumers and their family networks: A scoping review.

J Psychiatr Ment Health Nurs. 2024-8

[6]
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.

Cochrane Database Syst Rev. 2013-10-9

[7]
G-CSF and GM-CSF for treating or preventing neonatal infections.

Cochrane Database Syst Rev. 2003

[8]
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.

Eur J Cancer. 2007-1

[9]
Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.

Cochrane Database Syst Rev. 2022-10-17

[10]
Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer.

Cochrane Database Syst Rev. 2021-10-7

引用本文的文献

[1]
A Puerperal Patient with Leukopenia During Vancomycin Administration: A Case Report and Review of the Literature.

Int J Mol Sci. 2025-7-9

[2]
Diagnosis and management of neutropenia.

Blood Res. 2025-5-26

[3]
Secondary Neutropenias.

Biomedicines. 2025-2-17

[4]
Antibacterials with Novel Chemical Scaffolds in Clinical Development.

Drugs. 2025-3

[5]
Mandatory surveillance of bacteremia conducted by automated monitoring.

Front Public Health. 2024-12-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索